Long-term palliation of tetralogy of Fallot in dogs by use of a modified Blalock-Taussig shunt.

J Am Vet Med Assoc

Department of Clinical Science, Royal Veterinary College, North Mymms, Hatfield, Hertfordshire, AL9 7TA, England.

Published: September 2007

Objective: To describe a modified Blalock-Taussig shunt (mBT) procedure and assess its use in dogs with clinical signs associated with tetralogy of Fallot (TOF).

Design: Descriptive report.

Animals: 6 dogs with severe TOF-associated clinical signs.

Procedures: Each dog had TOF (confirmed echocardiographically or angiographically) and underwent an mBT shunt procedure for surgical palliation of signs. The surgery was performed through a left fourth rib resection or a left fifth intercostal thoracotomy. The left subclavian artery was dissected free from surrounding mediastinal tissue. The main pulmonary artery trunk was exposed through an incision in the overlying pericardium. A shunt comprised of a 6-mm-diameter tube of expanded polytetrafluoroethylene (5 dogs) or a segment of carotid artery (1 dog) was sutured end to side between the left subclavian artery and pulmonary artery trunk.

Results: 5 of the 6 dogs survived the immediate postoperative period. The dog that died shortly after surgery was the smallest of the dogs (weight, 2.9 kg [6.38 lb]) and had received the carotid artery autograft. Three dogs survived long term and 2 dogs died of unknown causes 6 years after undergoing the mBT shunt procedure. In all dogs that survived the mBT procedure, shunt patency was confirmed and quality of life appeared improved.

Conclusions And Clinical Relevance: These findings have suggested that the mBT shunt procedure safely provides long-term palliation of TOF-associated clinical signs in dogs. In addition, it may offer an effective low-risk and lower-cost alternative to open heart repair of TOF.

Download full-text PDF

Source
http://dx.doi.org/10.2460/javma.231.5.721DOI Listing

Publication Analysis

Top Keywords

mbt shunt
12
shunt procedure
12
dogs survived
12
dogs
10
long-term palliation
8
tetralogy fallot
8
modified blalock-taussig
8
blalock-taussig shunt
8
mbt procedure
8
clinical signs
8

Similar Publications

Background: While several studies have explored the outcomes of transcatheter interventions for modified Blalock-Taussig shunts (MBTSs) in a broad range of congenital heart diseases, none have specifically examined the interventions in patients with hypoplastic left heart syndrome (HLHS) who underwent Norwood palliation (NP).

Methods: This retrospective study was conducted between 2020 and 2024, when 24 urgent interventions were performed on 17 patients at our center. We recorded several key outcomes, including early and late intervention-related complications, the need for reintervention, the interval between the NP and the first intervention, shunt patency following the intervention, associated morbidities, and thrombosis-related sudden events.

View Article and Find Full Text PDF

Background: Our study focuses on the technique and results of interventional dilation and stenting of the modified Blalock-Taussig shunt (MBTS) performed in our center, providing a comprehensive review of our practice over the past 4 years.

Methods: 42 catheter interventions on MBTS performed on 32 patients between January 2020 and May 2024 included 11 balloon dilatations and 31 stenting procedures. They were analyzed retrospectively.

View Article and Find Full Text PDF
Article Synopsis
  • Cyanotic congenital heart diseases make up 40-45% of congenital heart conditions, and for some patients, modified BT (MBT) and central shunt (CS) are common procedures when primary repair isn’t suitable.
  • The study analyzed data from 62 pediatric patients who underwent these procedures, focusing on factors such as demographics, surgery details, and postoperative outcomes, categorizing patients based on cardiac anatomy and other conditions.
  • Results showed no significant differences in immediate surgical outcomes between MBT and CS, but a high incidence of congestive heart failure was associated with increased mortality, highlighting the importance of shunt size and placement in reducing risks.
View Article and Find Full Text PDF

Intravenous infusion of cardiac progenitor cells in animal models of single ventricular physiology.

Eur J Cardiothorac Surg

October 2023

Department of Cardiovascular Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences and Okayama University Hospital, Okayama, Japan.

Objectives: The goal of this study was to identify the practical applications of intravenous cell therapy for single-ventricle physiology (SVP) by establishing experimental SVP models.

Methods: An SVP with a three-stage palliation was constructed in an acute swine model without cardiopulmonary bypass. A modified Blalock-Taussig (MBT) shunt was created using an aortopulmonary shunt with the superior and inferior venae cavae (SVC and IVC, respectively) connected to the left atrium (n = 10).

View Article and Find Full Text PDF

Background: To the best of our knowledge, no study has been made until now to determine whether the ratio between pulmonary and systemic blood flow (p/s) in the pre-stage II (PS2) or pre-Glenn stage can predict the outcome in patients with hypoplastic left heart syndrome (HLHS) who underwent Norwood (NW) palliation.

Patients And Methods: From January 2016 to August 2022, 80 cardiac catheterizations in 69 patients with HLHS in NW palliation stage with modified Blalock-Taussig shunt (MBTS) were retrospectively recruited. The p/s was measured under stable conditions using the Fick formula.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!